S
Steven E. Nissen
Researcher at Cleveland Clinic
Publications - 615
Citations - 68676
Steven E. Nissen is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Intravascular ultrasound & Coronary artery disease. The author has an hindex of 98, co-authored 569 publications receiving 61223 citations. Previous affiliations of Steven E. Nissen include Cairo University & Cleveland Clinic Lerner College of Medicine.
Papers
More filters
Journal Article
Abstract 12252: Effects of the Cholesteryl Ester Transfer Protein Inhibitor, Evacetrapib, Administered as Monotherapy or in Combination With Statins on Cholesterol Efflux and HDL Particles in Patients With Dyslipidemia
Daniel J. Rader,Giacomo Ruotolo,John P. Kane,Ming-Dauh Wang,Kathryn A. Krueger,Steven E. Nissen,Stephen J. Nicholls,Bryan Brewer +7 more
TL;DR: In subjects with elevated LDL-C or low HDL-C, EVA alone and combined with statins increased global, ABCA1- and non-ABCA 1-mediated cholesterol efflux, accompanied by a significant increase in preβ-1 and large and very large HDL particles.
Journal ArticleDOI
Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma—Reply
Journal ArticleDOI
Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography
Muhammad Hammadah,Mohammed Qintar,Steven E. Nissen,Julie St. John,Saqer Alkharabsheh,Motunrayo Mobolaji-Lawal,Femi Philip,Kiyoko Uno,Yu Kataoka,Brett Babb,Roman Poliszczuk,Samir R. Kapadia,E. Murat Tuzcu,Paul Schoenhagen,Stephen J. Nicholls,Rishi Puri,Rishi Puri +16 more
TL;DR: This work proposes a novel means of more accurately assessing plaque volume across whole aortic segments using computed tomography angiography (CTA) imaging, and provides an initial validation of cross-sectional volumetric aortsic atheroma assessment using CTA.
Journal ArticleDOI
Coronary atherosclerosis in diabetic subjects: clinical significance, anatomic characteristics, and identification with in vivo imaging
TL;DR: Modem clinical imaging modalities allow the assessment of early atherosclerotic changes in coronary arteries; however, prospective evidence that atherosclerosis imaging impacts on clinical outcome is not yet available and future studies are necessary.
Journal ArticleDOI
Identification of the metabolic syndrome and imaging of subclinical coronary artery disease: early markers of cardiovascular risk.
TL;DR: Although further evaluation of the potential role for the emerging biomarkers and imaging techniques in the setting of the metabolic syndrome is needed, it is obvious that cardiovascular nurses need to develop a heightened awareness of patients at risk for future events.